Worldwide Clinical Trials Phase I Unit
Welcome,         Profile    Billing    Logout  
 1 Trial 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bass, Robert
NCT06488209: Single and Multiple Ascending Dose Study in Healthy Participants and Participants With an Autoimmune Disease

Recruiting
1
72
US
LAD191, Placebo
Almirall, S.A.
Healthy Volunteers, Autoimmune Disease
12/24
12/24
NCT05860933: A Study of the Effects of Itraconazole or Carbamazepine on LY3537982 in Healthy Participants

Completed
1
30
US
LY3537982, Olomorasib, Itraconazole, Carbamazepine
Eli Lilly and Company, Loxo Oncology, Inc.
Healthy
08/23
08/23
NCT06126042: Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route

Recruiting
1
330
US
Test Product, Proposed Biosimilar, Reference product, US Orencia, Reference Medicinal Product, EU Orencia
Dr. Reddy's Laboratories Limited
Rheumatoid Arthritis
 
 
NCT06107205: Bioequivalence of TTYP01 Tablets in Healthy Adult Subjects

Completed
1
29
US
TTYP01, Edaravone tablets, Radicava, Edaravone injection, Radicava ORS, Edaravone ORS
Auzone Biological Technology Pty Ltd
Healthy Adult Subjects
12/23
12/23
NCT05579314: XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)

Active, not recruiting
1
152
US
XW014, Placebo
Sciwind Biosciences USA Co., Ltd.
Type 2 Diabetes Mellitus
02/25
03/25
NCT06310551: First Time in Human Study of Long Acting VH4524184 Formulations

Recruiting
1
72
US
Oral VH4524184, VH4524184 Formulation A SC, Placebo Formulation A SC, rHuPH20, PH20, Halozyme ENHANZE, VH4524184 Formulation B SC, Placebo Formulation B SC, VH4524184 Formulation C SC, Placebo Formulation C SC, VH4524184 Formulation A IM, Placebo Formulation A IM, VH4524184 Formulation B IM, Placebo Formulation B IM
ViiV Healthcare, GlaxoSmithKline
HIV Infections
03/27
01/28
NCT06370728: A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants

Completed
1
30
US
Orforglipron, LY3502970, Carbamazepine
Eli Lilly and Company
Healthy
07/24
07/24
NCT06702462: A Study to Assess the Potential for Airway Sensitivity Reactions With Propellants HFA-152a (Test) and HFA-134a (Reference) Administered Via Pressurized Inhalers in Adults With Mild Asthma

Not yet recruiting
1
16
US
HFA-152A propellant, HFA-134A propellant
GlaxoSmithKline
Asthma
02/25
02/25

Download Options